TriMas (NASDAQ:TRS) Downgraded to Sell Rating by StockNews.com

StockNews.com downgraded shares of TriMas (NASDAQ:TRS) from a hold rating to a sell rating in a research note released on Tuesday.

Separately, BWS Financial reaffirmed a “buy” rating and issued a $40.00 price target on shares of TriMas in a research note on Tuesday.

TriMas Price Performance

Shares of TRS stock opened at $26.18 on Tuesday. The firm’s 50 day moving average price is $25.86 and its two-hundred day moving average price is $25.82. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.48 and a current ratio of 2.82. TriMas has a 52-week low of $22.45 and a 52-week high of $28.51. The stock has a market cap of $1.06 billion, a PE ratio of 40.91 and a beta of 0.66.

TriMas (NASDAQ:TRS) last posted its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.14). The company had revenue of $229.36 million during the quarter, compared to the consensus estimate of $239.33 million. TriMas had a return on equity of 9.61% and a net margin of 4.44%. The firm’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.57 earnings per share. As a group, analysts forecast that TriMas will post 1.75 EPS for the current year.

TriMas Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th will be given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Tuesday, November 5th. TriMas’s dividend payout ratio is currently 25.00%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets lifted its stake in TriMas by 79.8% in the first quarter. BNP Paribas Financial Markets now owns 20,225 shares of the industrial products company’s stock valued at $541,000 after buying an additional 8,978 shares in the last quarter. Quantbot Technologies LP lifted its holdings in shares of TriMas by 5.7% in the first quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock valued at $239,000 after purchasing an additional 478 shares in the last quarter. First Eagle Investment Management LLC grew its holdings in shares of TriMas by 109.2% during the first quarter. First Eagle Investment Management LLC now owns 190,206 shares of the industrial products company’s stock worth $5,084,000 after buying an additional 99,300 shares in the last quarter. Vanguard Group Inc. boosted its position in TriMas by 2.3% during the 1st quarter. Vanguard Group Inc. now owns 4,358,524 shares of the industrial products company’s stock worth $116,503,000 after acquiring an additional 100,068 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of TriMas by 6.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 23,870 shares of the industrial products company’s stock worth $639,000 after acquiring an additional 1,478 shares in the last quarter. 99.42% of the stock is currently owned by institutional investors.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.